Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.49 |
| ▸ | CD274 | Q9NZQ7 | 10/20 | 0.48 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19923214 | 0.92 | CD274 (0.54) | CD274MRGPRX4ALDH1A1MAPTCYP1A2 | |
| SCHEMBL19929652 | 0.86 | ALDH1A1 (0.48) | PIK3CDCD274ALDH1A1MAPTCYP1A2 | |
| SCHEMBL19929645 | 0.86 | ALDH1A1 (0.60) | ALDH1A1MAPTCYP1A2NPC1RAB9A | |
| SCHEMBL19929641 | 0.85 | ALDH1A1 (0.56) | CD274ALDH1A1MAPTCYP1A2NPC1 | |
| SCHEMBL19929651 | 0.85 | ALDH1A1 (0.50) | CD274ALDH1A1MAPTCYP1A2NPC1 | |
| SCHEMBL19929664 | 0.85 | ALDH1A1 (0.47) | CD274ALDH1A1MAPTCYP1A2NPC1 | |
| SCHEMBL19929654 | 0.85 | ALDH1A1 (0.45) | PIK3CDCD274ALDH1A1MAPTCYP1A2 | |
| SCHEMBL16554820 | 0.84 | CD274 (0.66) | CD274PDCD1 | |
| SCHEMBL18728634 | 0.83 | CD274 (0.46) | CD274MRGPRX4ALDH1A1MAPTCYP1A2 | |
| SCHEMBL19923196 | 0.82 | ALDH1A1 (0.67) | ALDH1A1MAPTCYP1A2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065917-A1 | IMMUNE CHECKPOINT INHIBITORS, COMPOSITIONS AND METHODS THEREOF | POLARIS PHARMACEUTICALS, INC. (JP) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065917-A1 | IMMUNE CHECKPOINT INHIBITORS, COMPOSITIONS AND METHODS THEREOF | CD274, PDCD1, PDCD1LG2 | PIK3CD 2793/4885CD274 1/4885MRGPRX4 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.